Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609

Watchlist Manager
Shanghai HeartCare Medical Technology Corp Ltd Logo
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
Watchlist
Price: 29.8 HKD 1.19% Market Closed
Market Cap: 1.2B HKD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

6609 price has not been updated for more than 1 year. This may indicate that the stock has been delisted.

The Relative Value of one Shanghai HeartCare Medical Technology Corp Ltd stock under the Base Case scenario is 13.76 HKD. Compared to the current market price of 29.8 HKD, Shanghai HeartCare Medical Technology Corp Ltd is Overvalued by 54%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
13.76 HKD
Overvaluation 54%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.9
P/S
P/S
Price to Sales
3.9
vs History
55
vs Industry
27
Median 3Y
4.5
Median 5Y
4
Industry
2.2
Forward
2.6
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-6.8
Median 5Y
-7.1
Industry
21.9
Forward
28.6
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-6.2
Median 5Y
-7.5
Industry
13.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-4.3
Median 5Y
-4.6
Industry
19.3
More Details
1
P/B
P/B
Price to Book Value
1
vs History
31
vs Industry
61
Median 3Y
0.8
Median 5Y
0.9
Industry
2.1
More Details
1.4
EV/S
EV/S
Enterprise Value to Sales
1.4
vs History
34
vs Industry
51
Median 3Y
0.7
Median 5Y
0.7
Industry
2.3
Forward
1
More Details
2.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.2
vs History
31
vs Industry
61
Median 3Y
1.1
Median 5Y
1.1
Industry
4.8
More Details
22.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
22.3
vs History
2
vs Industry
52
Median 3Y
-0.6
Median 5Y
-1.1
Industry
11.5
Forward
7.1
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
49
Median 3Y
-1.1
Median 5Y
-2.2
Industry
15.6
Forward
12.2
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
53
Median 3Y
-1.2
Median 5Y
-1.7
Industry
13.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
43
Median 3Y
-1
Median 5Y
-1.4
Industry
17.3
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
31
vs Industry
55
Median 3Y
0.4
Median 5Y
0.6
Industry
1.8
More Details

Multiples Across Competitors

Competitors Multiples
Shanghai HeartCare Medical Technology Corp Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
1.2B HKD 3.9 -79.7 22.3 -27.4
US
Abbott Laboratories
NYSE:ABT
229.6B USD 5.4 17 22.1 31.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
189.4B USD 21.7 76.5 61.1 73.5
US
Boston Scientific Corp
NYSE:BSX
153.7B USD 8.8 75.6 35.6 49.4
US
Stryker Corp
NYSE:SYK
145.5B USD 6.4 48.6 25.1 30.3
IE
Medtronic PLC
NYSE:MDT
107.1B USD 3.2 25.1 13.5 19
DE
Siemens Healthineers AG
XETRA:SHL
53.3B EUR 2.3 26.8 15.5 22.1
US
Becton Dickinson and Co
NYSE:BDX
47.9B USD 2.3 31.5 12.7 23.8
US
Edwards Lifesciences Corp
NYSE:EW
44.2B USD 8 10.6 24.2 26.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.4B USD 9.8 42.9 30.4 34
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
267.6B CNY 7.5 24 21 21

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 252,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.